Author(s): Akhmetova М., Nigmatullina R., Mindubaуeva F., Tykezhanova G., Niyazova Y., Lepesbayeva G

Email(s): meruzhan2@mail.ru

DOI: 10.52711/0974-360X.2022.00020   

Address: Akhmetova М.1, Nigmatullina R.2, Mindubaуeva F.3, Tykezhanova G.1, Niyazova Y.3, Lepesbayeva G3
1Karagandy University of the Name of Academician E.A. Buketov» NLC, Kazakhstan.
2Kazan State Medical University, Russia.
3Karaganda Medical University» NCJSC, Kazakhstan.
*Corresponding Author

Published In:   Volume - 15,      Issue - 1,     Year - 2022


ABSTRACT:
Serotonin plays an important role in the cardiovascular system and is a humoral system of regulators and modulators of physiological processes. Under pathological conditions, it can result in developing some factors contributing to the development of diseases, such as atherosclerosis, arterial and pulmonary hypertension. The 5-HT4 and 5-HT2B receptors have been identified in cardiomyocytes, which are involved in the regulation of the inotropic function of the myocardium. The serotonergic system is an essential link in embryonic development. As a key signaling molecule in heart progenitor cells, serotonin is involved in the development and differentiation of myocardial cells as well as the separation of the heart chambers. Therefore, interfering with this system in the womb and changing its concentration can disrupt normal development of the heart. It has been established that any change in the concentration of serotonin created by the blockade of the synthesis of serotonin and the membrane serotonin transporter in the embryonic period of ontogenesis, leads to a decrease in the contraction strength of the right ventricular myocardium in 7-day-old infant rats. However, at the age of 14 days, intergroup differences are not manifested. At 7 days of age, the response of the contraction strength to the maximum concentration of serotonin is lower in infant rats with an excess of serotonin and higher in infant rats with its deficiency, as compared to those animals in the control group. At the age of 14 days, the response of the contraction strength in both experimental groups has been reduced in comparison with the animals in the control group.


Cite this article:
Akhmetova М., Nigmatullina R., Mindubaуeva F., Tykezhanova G., Niyazova Y., Lepesbayeva G. Features of the effect of serotonin on the inotropic function of the right ventricular myocardium in the early postnatal period in infant rats with altered serotonin levels during their embryogenesis. Research Journal of Pharmacy and Technology. 2022; 15(1):122-6. doi: 10.52711/0974-360X.2022.00020

Cite(Electronic):
Akhmetova М., Nigmatullina R., Mindubaуeva F., Tykezhanova G., Niyazova Y., Lepesbayeva G. Features of the effect of serotonin on the inotropic function of the right ventricular myocardium in the early postnatal period in infant rats with altered serotonin levels during their embryogenesis. Research Journal of Pharmacy and Technology. 2022; 15(1):122-6. doi: 10.52711/0974-360X.2022.00020   Available on: https://rjptonline.org/AbstractView.aspx?PID=2022-15-1-20


REFERENCES:
1.    Nadeev A.D., Zharkikh I.L., Avdonin P.P., Goncharov N.V. Serotonin and its receptors in the cardiovascular system. Experimental and Clinical Pharmacology. 2014; 77(5): 32-37.
2.    Sadykova D.I., Nigmatullina R.R., Aflyatumova G.N. The role of serotonergic system in cardiovascular diseases development in children. Kazan Medical Journal. 2015; 96(4): 65-69.
3.    Nedorezova R.S., Garipov T.V., Nigmatullina R.R. Influence of dantrolene and methoxiverapamil channels Сa2 + -channels on the rating myocardial myocardial function of rats with changed serotonin level. Scientific notes of the Kazan State Academy of Veterinary Medicine named after N.E. Bauman. 2019; 240(4): 123-127.
4.    Daly E., Tricklebank M.D., Wichers R. The serotonin system. History, neuropharmacology, and pathology. Academic Press, 2019.
5.    Selim A.M., Sarswat N., Kelesidis I., Iqbal M., Chandra R., Zolty R. Plasma Serotonin in Heart Failure: Possible Marker and Potential Treatment Target. Heart, Lung and Circulation. 2017; 26: 442-449.
6.    Estelle A., Roland L., Sylvia D., Jean P.M., Laurent M. Serotonin contribution to cardiac valve degeneration: new insights for novel therapies? Pharmacol Res. 2019; 140: 33-42.
7.    Wirth A., Holst K., Ponimaskin E. How serotonin receptors regulate morphogenic signalling in neurons. Progress in Neurobiology. 2017; 151: 35-56.
8.    Abbas A.C., Hamza Al-Kraity W.R., Abbas E.C. Effect antioxidant and serotonin level in the sera on type II diabetes mellitus males patients and compare with control group. Research Journal of Pharmacy and Technology. 2019; 12(5): 2453-2460.
9.    Venkatesha G., Kalaiyarasia C., Ramanathana M. Antidepressant like Effect of Gabapentin decreases the immobility time in despair animal models in mice: roll of serotonergic system in it. Research Journal of Pharmacy and Technology. 2011; 4(11): 1702-1706.
10.    Swarup P. D.,Saha P. Development and optimization of orodispersible tablets of serotonin hydrochloride. Research Journal of Pharmaceutical Dosage Forms and Technolog. 2018; 10(1): 13-16.
11.    Matthes S., Bader M. Peripheral Serotonin Synthesis as a New Drug Target. Trends Pharmacol Sci. 2018; 39: 560-572.
12.    Akhmetzyanov V.F., Yakupova A.F., Nigmatullina R.R. Age-related features of inotropic effect of serotonin on rat myocardium. Kazan Medical Journal. 2010; 91(4): 467-471.
13.    Valeev A.M., Abzalov N.I., Abzalov R.A., Nigmatullina R.R., Abzalov R.R., and Nikitin A.S. Influence of 5-HT2 Receptor Agonist on Cardiac Pumping Function of Trained Offspring of Trained Rats. Bulletin of Experimental Biology and Medicine. 2012; 153(3): 315-318.
14.    Ayme-Dietrich E., Aubertin-Kirch G., Maroteaux L., Monassier L. Cardiovascular remodeling and the peripheral serotonergic system. Arch Cardiovasc Dis. 2017; 110: 51-59.
15.    Ayme-Dietrich E., Marzak H., Lawson R., Mokni W., Wendling O., Combe R., Becker J., Fertak E. L., Champy M. F., Matz R., Andriantsitohaina R., Doly S., Boutourlinsky K., Maroteaux L., Monassier L. Contribution of serotonin to cardiac remodeling associated with hypertensive diastolic ventricular dysfunction in rats. J Hypertens. 2015; 33(11): 2010-2310.
16.    Mindubaуeva F., Niyazova Y., Nigmatullina R., Sadykova D. , Akhmaltdinova L., Salikhova Y., Kadyrova I., Akhmetova M., Sabirova D. Membrane serotonin transporter as a Biomarker of Pulmonary arterial hypertension in children with Congenital Heart Defect. Research Journal of Pharmacy and Technology. 2020; 13(5): 2435-2438.
17.    Amador H.B., M. McDonald М. Molecular and functional characterization of the Gulf toadfish serotonin transporter SLC6A4. The Journal of Experimental Biology. 2018; 221(7): 1-11.
18.    Rudnick G., Sandtner W. Serotonin transport in the 21st century. The Journal of General Physiology. 2019; 151(11): 1248–1264.
19.    David D.J.; Gardier A.M. Les bases de pharmacologie fondamentale du système sérotoninergique: application à la réponse antidépressive. L'Encéphale. 2016; 42(3): 255–263.
20.    John D., McCorvy, Roth B.L. Structure and function of serotonin G protein-coupled receptors. Pharmacol. Ther. 2015; 150: 129-142.
21.    Ayme-Dietrich E., Lawson R., Côté F., Tapia C., Silva S., Ebel C., Hechler B., Gachet C. Serotonergic 5-HT2B receptors in mitral valvulopathy: bone marrow mobilization of endothelial progenitors. Br J Pharmacol. 2017; 174(22): 5-35.
22.    Margaret Shanthi F.X., Kumar A., Bernice F., Ernest K. Dose dependent anxiolytic activity of verapamil in mice in comparison to saline and fluoxetine. Research Journal of Pharmacy and Technology. 2014; 7(3): 322-327.
23.    Dixit N., Trivedi A., Ahirwar D. Synthesis of Citosan Nanocarrier Systems for Improving SSRI-Fluoxetine Efficacy in MDD. Research Journal of Pharmacy and Technology. 2020; 13(5): 2387-2392.
24.    Patel M.A., Patel C.M., Patel D.B., Anand I.S., Patel C.N. A Review on Novel Strategies for Pharmacotherapy of Depression. Research J. Pharmacology and Pharmacodynamics. 2010; 2(2): 153-159.
25.    Zmudzka E., Salaciak K., Sapa J., Pytka K. Serotonin receptors in depression and anxiety: Insights from animal studies. Life Sciences. 2018; 210: 106-124.
26.    Zullino S., Simoncini T. Impact of selective serotonin reuptake inhibitors (SSRIs) during pregnancy and lactation: a focus on short and long-term vascular effects. Vasс Pharmacol. 2018; 108: 74-76.
27.    Hutchison S., Mâsseb L., Pawluskic J., Oberlandera T. Perinatal selective serotonin reuptake inhibitor (SSRI) effects on body weight at birth and beyond: a review of animal and human studies. Reprod. Toxicol. 2018; 77: 109-121.
28.    Charlton R.A., Jordan S., Pierini A., Garne E., Neville A.J., Hansen A.V., Bos H.J. Selective serotonin reuptake inhibitor prescribing before, during and after pregnancy: a population-based study in six European regions. BJOG Int. J. Obstet. Gynaecol. 2015; 122(7): 1010-1020.
29.    Higashi C., Sartoretto S.M., Echem C., Cruz Lucchetti B.F., Carvalho M.H., Pelosi G., Pinge F.P., Gerardin D.C., Moreira E., Akamine E., Ceravolo G. Intrauterine and lactational exposure to fluoxetine enhances endothelial modulation of aortic contractile response in adult female rats. Vasc. Pharmacol. 2018; 17: 1537-1891.
30.    Pytka K., Podkowa K., Rapacz A., Podkowa A., Żmudzka E., Olczyk A., Sapa J., Filipek B. The role of serotonergic, adrenergic and dopaminergic receptors in antidepressant-like effect. Pharmacol Rep. 2016; 68(2): 263-274.
31.    Yogita S., Kumar J.A. Effects of maternal fluoxetine treatment on behavioural despair and learned helplessness parameters of depression in the rat progeny. Research Journal of Pharmacology and Pharmacodynamics. 2016; 8(3):106-110.
32.    Yogita S., Kumar J.A. Effects of maternal fluoxetine treatment on anxiety parameters in the rat progeny. Research Journal of Pharmacology and Pharmacodynamics. 2017; 9(3): 137-141.
33.    Zaheer Z., Shaikh O., Thorat S., Ahmed R.Z. Development and validation of uv spectrophotometric method of fluoxetine hydrochloride in bulk and pharmaceutical formulation. Asian J. Research Chem. 2010; 3(3): 545-548.
34.    Sadler W. Selective serotonin reuptake inhibitors (SSRIs) and heart defects: Potential mechanisms for the observed associations. Reprod Toxicol. 2011; 32(4): 484–489.
35.    Akhmetzyanov V.F., Nigmatullina R.R. Akhmetzyanova A.F., Latfullin I.A. Positive inotropic effect of serotonin on the heart in postnatal ontogenesis. Arkh. Klin. Eksp. Med. 2004; 1: С. 22–25.
36.    Woo A.Y., Xiao R.P. Beta-Adrenergic receptor subtype signaling in heart: from bench to bedside. Acta Pharmacol. 2012; 33: 335–341.

Recomonded Articles:

Research Journal of Pharmacy and Technology (RJPT) is an international, peer-reviewed, multidisciplinary journal.... Read more >>>

RNI: CHHENG00387/33/1/2008-TC                     
DOI: 10.5958/0974-360X 

0.38
2018CiteScore
 
56th percentile
Powered by  Scopus


SCImago Journal & Country Rank


Recent Articles




Tags


Not Available